Yoon, J.; Song, J.J.; Lee, S.-W.; Park, H.J.; Park, Y.-B.
Clinical Implications of Point-of-Care Measurement of Adalimumab Concentration and Anti-Adalimumab Antibodies in Patients with Rheumatoid Arthritis and Ankylosing Spondylitis. Int. J. Mol. Sci. 2025, 26, 8741.
https://doi.org/10.3390/ijms26178741
AMA Style
Yoon J, Song JJ, Lee S-W, Park HJ, Park Y-B.
Clinical Implications of Point-of-Care Measurement of Adalimumab Concentration and Anti-Adalimumab Antibodies in Patients with Rheumatoid Arthritis and Ankylosing Spondylitis. International Journal of Molecular Sciences. 2025; 26(17):8741.
https://doi.org/10.3390/ijms26178741
Chicago/Turabian Style
Yoon, Jiyeol, Jason Jungsik Song, Sang-Won Lee, Hee Jin Park, and Yong-Beom Park.
2025. "Clinical Implications of Point-of-Care Measurement of Adalimumab Concentration and Anti-Adalimumab Antibodies in Patients with Rheumatoid Arthritis and Ankylosing Spondylitis" International Journal of Molecular Sciences 26, no. 17: 8741.
https://doi.org/10.3390/ijms26178741
APA Style
Yoon, J., Song, J. J., Lee, S.-W., Park, H. J., & Park, Y.-B.
(2025). Clinical Implications of Point-of-Care Measurement of Adalimumab Concentration and Anti-Adalimumab Antibodies in Patients with Rheumatoid Arthritis and Ankylosing Spondylitis. International Journal of Molecular Sciences, 26(17), 8741.
https://doi.org/10.3390/ijms26178741